Rambam Health Care Campus commonly called Rambam Hospital, is a hospital in the Bat Galim neighborhood of Haifa, Israel founded in 1938, 10 years before the establishment of the State of Israel.

There are 1,040 beds in Rambam Medical Center; Oncology.

During the past decade, Rambam Medical Center; Oncology conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rambam Medical Center; Oncology" #1 sponsor was "Hoffmann-La Roche" with 24 trials, followed by "Merck Sharp & Dohme LLC" with 6 trials sponsored, "Rambam Health Care Campus" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rambam Medical Center; Oncology" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "BioLineRx, Ltd." with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "British Medical Research Council" with 1 trials as a collaborator and "Clalit Health Services" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Rambam Medical Center; Oncology" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Non-Small Cell Lung Cancer" (4 trials), "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials) and "Solid Tumors" (2 trials). Many other conditions were trialed in "Rambam Medical Center; Oncology" in a lesser frequency.

Most popular intervention types in "Rambam Medical Center; Oncology" are "Drug" (40 trials), "Biological" (6 trials), "Other" (6 trials), "Radiation" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (12 trials), "Gemcitabine" (8 trials), "Carboplatin" (7 trials), "Placebo" (7 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Rambam Medical Center; Oncology" are 41 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rambam Medical Center; Oncology". undefined are not yet recruiting, 13 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Rambam Medical Center; Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rambam Medical Center; Oncology, 3 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".